- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Dongbu HiTek today announced it has licensed the ARM926EJ-S™ processor to include in its expanding Intellectual Property (IP) Portfolio. Optimized for Dongbu's processing at the 130 nanometer (nm) node, the newly added ARM® IP enables reduced time and cost in designing System-on-Chip (SoC) solutions that target the increasingly complex mobile handset and consumer products coming to market.
As a member of the ARM9E™ family of processors, the ARM926EJ-S processor enables multi-tasking applications where full memory management, high performance, small die size, and low power are all important. It also supports 32-bit ARM and 16-bit ARM Thumb® instruction sets as well as the efficient execution of Java byte codes.
"We are pleased to extend our relationship to make the ARM926EJ-S processor available to our foundry customers," said Dr. Jae Song, EVP of Dongbu HiTek. "Fabless firms using the ARM926EJ-S processor optimized for our 130nm process should be able to shrink SoC development time by several months while also realizing significant cost savings." He confirmed that the ARM926EJ-S processor represents the third ARM processor added to Dongbu's IP Portfolio, preceded by the ARM7TDMI® processor used to design chips for low-cost mobile handsets such as MP3 players and the ARM922T™ processor used to design chips for wireless communications.
"We view ARM as the leading developer of 32-bit processors, which continue to have a leading position in mobile phone applications," added Dr. Song. "The increasingly complex products coming to market - including DMB phones, PMPs, set-top boxes, digital cameras and game consoles - all need the performance, small footprint and low-power consumption that the newly added ARM processor provides."
Dr. Song underscored Dongbu's expanding capabilities to provide best-in-class SoC design support. "In addition to the ARM processors, we also offer IP that enables the integration of Analog-to-Digital Conversion, Phased Locked Loop (PLL) and USB Communications functions." He noted that Dongbu's licensed agreement with ARM in January, 2007 resulted in the ARM® Metro™ low-power high-density standard cell library, part of its family of Artisan® physical IP, being added to the Korean foundry's design support resources.
"The addition of the ARM926EJ-S processor to Dongbu's portfolio of ARM IP, together with our market-leading physical IP products, will enable Dongbu to provide our mutual customers with a class-leading solution for developing low-power, high-performance digital devices," said Graham Budd, Executive Vice President and General Manager, Processor Division, ARM. "The ARM926EJ-S processor has been one of ARM's most popular processors and to date has been widely used in applications including next generation smart phones, communicators & PDAs, 3G baseband, digital still cameras and automotive infotainment."
About Dongbu HiTek
Dongbu HiTek Co., Ltd. emerged from the synergistic fusion of Dongbu Hannong Chemicals and Dongbu Electronics in 2007. With a lineage of technology innovation spanning more than half a century, Dongbu HiTek is structured to maintain a strong customer focus and global competitiveness across its three major businesses, namely: Agriculture encompassing products and technical services related to the eco-friendly growth and care of crops and livestock as well as to bio medical supplies, healthful/functional food and agricultural distribution ; Materials spanning petrochemicals, metals and global trading as well as high-tech nanotechnology materials for semiconductors, electronic displays ; Semiconductor focusing on advanced wafer foundry processing for specialty devices such as CMOS Image Sensors as well as System-on-Chip (SoC) solutions for mobile handset and display markets. Committed to improving the quality of life through the use of advanced technologies, Dongbu HiTek is well positioned to deliver best-in-class products and services to the bio and semiconductor industries. For more information, visit http://www.dongbuhitek.com
ARM, ARM7TDMI and Thumb are registered trademarks of ARM Limited. ARM926EJ-S, ARM922T and Metro are trademarks of ARM Limited. Artisan and Artisan Components are registered trademarks of ARM Physical IP, Inc. All other brands or product names are the property of their respective holders. “ARM” is used to represent ARM Holdings plc; its operating company ARM Limited; and the regional subsidiaries ARM INC.; ARM KK; ARM Korea Ltd.; ARM Taiwan; ARM France SAS; ARM Consulting (Shanghai) Co. Ltd.; ARM Belgium N.V.; AXYS Design Automation Inc.; AXYS GmbH; ARM Embedded Solutions Pvt. Ltd.; ARM Physical IP, Inc.; and ARM Norway, AS.
For more information, please click here
Dongbu HiTek Semiconductor Korea/Asia
Kevin Lee, +82.17.337.4698
Dongbu HiTek Semiconductor USA/ Europe
Elizabeth Estrella-Basilio, +1-408-238-8822
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
A metal that behaves like water: Researchers describe new behaviors of graphene February 12th, 2016
Research reveals carbon films can give microchips energy storage capability: International team from Drexel University and Paul Sabatier University reveals versatility of carbon films February 11th, 2016
Graphene leans on glass to advance electronics: Scientists' use of common glass to optimize graphene's electronic properties could improve technologies from flat screens to solar cells February 12th, 2016
Breaking cell barriers with retractable protein nanoneedles: Adapting a bacterial structure, Wyss Institute researchers develop protein actuators that can mechanically puncture cells February 12th, 2016
Properties of Polymeric Nanofibers Optimized to Treat Damaged Body Tissues February 12th, 2016
Silicon-based metamaterials could bring photonic circuits February 1st, 2016
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016